Here you will find financial information about InDex and can subscribe to press releases and reports. If you have questions, please contact our IR contact.
Investors
Press releases
- InDex Pharmaceuticals gets patent for additional DIMS compounds granted in Europe07 April 2021 - Other press release
- InDex Pharmaceuticals enters agreement with Parexel Biotech for phase III clinical study of cobitolimod for ulcerative colitis30 March 2021 - Other press release
- InDex Pharmaceuticals Holding AB (publ) announces changes in the Nomination Committee for the 2021 Annual General Meeting15 March 2021 - Other press release
Year-end Report 2020
InDex Pharmaceuticals Holding AB (publ) published its year-end report for 2020 on February 25, 2021, at 08:00 a.m. CET.
Calender
- 23 April 2021Annual Report 2020
- 5 May 2021Interim report Q1 2021
- 3 June 2021Annual General Meeting 2021